Abstract PS3-04-21: Bridging the Reality Gap: A Multimodal Evaluation of Large Language Models for Real-World Breast Cancer Decision Support

Abstract Background: Large Language Models (LLMs) have shown promising accuracy in generating guideline-based cancer treatment recommendations. However, their alignment with real-world breast cancer management decisions remains poorly characterized. This study presents a novel benchmark evaluating LLM-generated recommendations against both clinical guidelines and actual treatments recorded in electronic health records (EHR), while also assessing the models’ capacity for patient-centered communication. Methods: We extracted structured and unstructured EHR data from 500 newly diagnosed non-metastatic breast cancer patients (2023-2025) at Penn Medicine, including imaging data. Each case was processed through a multi-turn, agent-based LLM prompting framework using a range of models, including general-purpose LLMs (GPT-4o, Claude 3.7, DeepSeek R1, Grok), as well as medically tuned models (MedGemma, HealthBench). Each model received basic case data and dynamically queried for additional clinical information before recommending a treatment plan. Recommendations were compared to (1) NCCN/ESMO guidelines and (2) the actual treatment received (ATR). Concordance rates, over-/under-treatment frequencies, and the “Reality Gap” (cases where recommendations matched guidelines but diverged from real-world practice) were analyzed. Propensity score-based causal inference was used to identify demographic and socioeconomic drivers of discordance. Additionally, a multidisciplinary panel rated LLM responses to common patient questions in terms of clarity, empathy, and shared decision-making support. Results: Across all models, guideline concordance was high (GPT-4o: 90.2%, Claude 3.7: 89.4%, Deepseek: 88.6%, MedGemma: 87.9%). However, concordance with real-world treatment was notably lower (GPT-4o: 67.8%, Claude 3.7: 65.1%, MedGemma: 62.3%), with LLMs generally recommending more intensive treatment than was actually administered. In 22.3% of cases, the LLM recommendation aligned with guidelines but diverged from the real-world decision, reflecting a significant “Reality Gap.” Multivariable analysis identified Medicaid insurance (OR 2.14, 95% CI 1.31-3.49), age ≥70 (OR 1.72, 95% CI 1.08-2.75), and documented treatment refusal as independent predictors of discordance. In the communication task (N=100 dialogues), GPT-4o showed relatively strong performance in accuracy (4.61/5) and decision support (4.55/5), though differences between models were modest. Conclusions: This study directly addresses a central question in AI-enabled oncology: how far are large language models (LLMs) from actual clinical decision-making? While LLMs are capable of generating medically sound and guideline-concordant recommendations, real-world factors—such as patient preferences, socioeconomic barriers, and health literacy—are often overlooked, despite playing a critical role in shaping care delivery. By jointly evaluating clinical validity and contextual fidelity, our framework quantifies the “reality gap” between LLM recommendations and actual treatment. Importantly, we do not advocate for LLMs to conform to all real-world deviations, nor should models be encouraged to offer suboptimal plans based on non-clinical attributes. Instead, our findings highlight the importance of using social context to enhance interpretation and patient-centered communication—without compromising evidence-based care. Our work provides a concrete model for evaluating and improving AI alignment with real-world clinical decisions in breast cancer care. Further analyses are underway to expand the scope and robustness of these findings. Citation Format: Z. Qu, X. Wang, S. Pei, Y. Fang. Bridging the Reality Gap: A Multimodal Evaluation of Large Language Models for Real-World Breast Cancer Decision Support [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PS3-04-21.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-02-17
DOI
https://doi.org/10.1158/1557-3265.sabcs25-ps3-04-21
Primary Topic
Machine Learning in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract PS3-04-21: Bridging the Reality Gap: A Multimodal Evaluation of Large Language Models for Real-World Breast Cancer Decision Support

X. Wang, Z. Qu, S. Pei, Y. Fang
Clinical Cancer Research
Machine Learning in Healthcare
article

Abstract PS3-04-21: Bridging the Reality Gap: A Multimodal Evaluation of Large Language Models for Real-World Breast Cancer Decision Support

X. Wang, Z. Qu, S. Pei, Y. Fang
article en

Abstract

Abstract Background: Large Language Models (LLMs) have shown promising accuracy in generating guideline-based cancer treatment recommendations. However, their alignment with real-world breast cancer management decisions remains poorly characterized. This study presents a novel benchmark evaluating LLM-generated recommendations against both clinical guidelines and actual treatments recorded in electronic health records (EHR), while also assessing the models’ capacity for patient-centered communication. Methods: We extracted structured and unstructured EHR data from 500 newly diagnosed non-metastatic breast cancer patients (2023-2025) at Penn Medicine, including imaging data. Each case was processed through a multi-turn, agent-based LLM prompting framework using a range of models, including general-purpose LLMs (GPT-4o, Claude 3.7, DeepSeek R1, Grok), as well as medically tuned models (MedGemma, HealthBench). Each model received basic case data and dynamically queried for additional clinical information before recommending a treatment plan. Recommendations were compared to (1) NCCN/ESMO guidelines and (2) the actual treatment received (ATR). Concordance rates, over-/under-treatment frequencies, and the “Reality Gap” (cases where recommendations matched guidelines but diverged from real-world practice) were analyzed. Propensity score-based causal inference was used to identify demographic and socioeconomic drivers of discordance. Additionally, a multidisciplinary panel rated LLM responses to common patient questions in terms of clarity, empathy, and shared decision-making support. Results: Across all models, guideline concordance was high (GPT-4o: 90.2%, Claude 3.7: 89.4%, Deepseek: 88.6%, MedGemma: 87.9%). However, concordance with real-world treatment was notably lower (GPT-4o: 67.8%, Claude 3.7: 65.1%, MedGemma: 62.3%), with LLMs generally recommending more intensive treatment than was actually administered. In 22.3% of cases, the LLM recommendation aligned with guidelines but diverged from the real-world decision, reflecting a significant “Reality Gap.” Multivariable analysis identified Medicaid insurance (OR 2.14, 95% CI 1.31-3.49), age ≥70 (OR 1.72, 95% CI 1.08-2.75), and documented treatment refusal as independent predictors of discordance. In the communication task (N=100 dialogues), GPT-4o showed relatively strong performance in accuracy (4.61/5) and decision support (4.55/5), though differences between models were modest. Conclusions: This study directly addresses a central question in AI-enabled oncology: how far are large language models (LLMs) from actual clinical decision-making? While LLMs are capable of generating medically sound and guideline-concordant recommendations, real-world factors—such as patient preferences, socioeconomic barriers, and health literacy—are often overlooked, despite playing a critical role in shaping care delivery. By jointly evaluating clinical validity and contextual fidelity, our framework quantifies the “reality gap” between LLM recommendations and actual treatment. Importantly, we do not advocate for LLMs to conform to all real-world deviations, nor should models be encouraged to offer suboptimal plans based on non-clinical attributes. Instead, our findings highlight the importance of using social context to enhance interpretation and patient-centered communication—without compromising evidence-based care. Our work provides a concrete model for evaluating and improving AI alignment with real-world clinical decisions in breast cancer care. Further analyses are underway to expand the scope and robustness of these findings. Citation Format: Z. Qu, X. Wang, S. Pei, Y. Fang. Bridging the Reality Gap: A Multimodal Evaluation of Large Language Models for Real-World Breast Cancer Decision Support [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PS3-04-21.

Clinical Cancer ResearchVol. 32(4_Supplement)
Pennsylvania State University (US), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), National Cancer Center (US), University of Pennsylvania (US)
Openalex Percentile: Top 51%
Machine Learning in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.